CAR T-Cell Therapy Market Experiences Rapid Uptake Across Key Regions

The global CAR T-cell therapy market has emerged as one of the most promising and rapidly expanding sectors in oncology, with immense potential to transform cancer treatment. By 2025, the market size is expected to be valued at US$5.8 billion and is anticipated to reach US$24 billion by 2032, growing at a compound annual growth rate (CAGR) of 25% during the forecast period of 2025-2032. This robust growth can be attributed to several factors, including the increasing prevalence of hematological malignancies and the expanding indications for CAR T-cell therapies in various oncology treatments.